Health Stroke Scale [NIHSS] 18 [9-32] vs. 10 [4-21]; p < 0.001), larger hematoma volume on admission (17.6 [6.9-47.7] vs. 10.6 [3.8-31.7] mL; p = 0.001), and more frequently unfavorable outcome 116/641; p < 0.001), and increased c-reactive-protein levels on admission ( p < 0.001; R 2 = 0.064). Adjusting for the abovementioned baseline confounders, multivariable logistic analyses revealed independent associations of NLROA with inhospital mortality (OR 0.967, 95% CI 0.939-0.997; p = 0.029). Conclusions: NLR represents an independent parameter associated with increased mortality in ICH patients. Stroke physicians should focus intensely on patients with increased NLR,
Neutrophil-to-Lymphocyte Ratio Is an
Inflammation plays an important role in cerebrovascular diseases [1] [2] [3] [4] , including intracerebral hemorrhage (ICH) [5] [6] [7] and is usually monitored using a variety of biochemical and hematological markers [8] [9] [10] [11] [12] . Neutrophil-to-lymphocyte ratio (NLR), calculated by the absolute neutrophil count divided by the absolute lymphocyte count, is increasingly recognized as a readily available and inexpensive biomarker for systemic inflammation [13] . NLR reflects the balance between innate (neutrophile granulocytes) and adaptive (lymphocytes) immune responses as neutrophil elevation and lymphocyte depletion indicate physiological stress [14, 15] .
Recently, in some ICH-studies, NLR has been associated with clinical endpoints [2, 12, [16] [17] [18] [19] . However, in ICH patients, little is known about the natural course of systemic inflammation during hospital stay and whether NLR is associated with short-term mortality. This study for the first time investigated (i) the course of NLR, (ii) parameters associated with NLR, and (iii) the clinical impact of NLR on mortality and functional outcome after ICH.
Methods

Patient Selection
We analyzed all consecutive patients with spontaneous ICH admitted to the Department of Neurology, University Hospital Erlangen, Germany, between 2006 and 2014 ( n = 960). By definition, we excluded secondary ICH etiologies, that is, ICH related to trauma, tumor, arteriovenous malformation, central venous thrombosis, subarachnoid hemorrhage or thrombolysis, as previously defined [20] . We did not include patients receiving permanent immunomodulatory treatments prior to admission, for example, consisting of corticosteroids, methotrexate, other cytostatic drugs and biologicals (monoclonal antibodies) and excluded all individuals with hematological, autoimmune, or infectious diseases. As 105 patients had no follow-up data, or refused consent, 855 patients participated in the final analysis.
Parameter Acquisition
As described previously [21] , we retrieved data of all patients from our institutional prospective database. We reviewed data for demographics, prior medical history, imaging, and in-hospital parameters (Glasgow Coma Scale [GCS], National Institute of Health Stroke Scale [NIHSS], ICH-score, blood pressure, mechanical ventilation, length of stay, external ventricular drainage, diagnosis of pneumonia, urinary tract infection and sepsis, as defined elsewhere) [22] [23] [24] [25] .
Laboratory parameters were retrieved from our institutional database. We investigated NLR that was obtained immediately upon admission (NLROA) and subsequently during hospital stay in the morning (NLR days 1, 2, 3, 5, 7, 10, and 14). However, in cases of infections and need of frequent blood controls, we did not consider this additional blood work taken during other times of the day to avoid confounding. NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count [5, 13] and average values for healthy controls (NLR = 2.24) were defined according to representative samples [26] . We chose to use a median split and 25th/75th percentile quartiles to categorize our ICH-patients.
We assessed patients' characteristics, for example, history of stroke, cardiovascular comorbidity, nicotine or alcohol abuse, using standardized mailed questionnaires. Semi-quantitative phone interviews were conducted -performed by physicians trained and certified for data collection on disability and quality of life -with patients or their closest relatives if the questionnaire was not returned within 2-4 weeks [21] . We contacted primary care physicians only in cases of insufficient data retrieval.
Outcome Measures
We obtained data on mortality and functional outcome as described above using the modified Rankin Scale (mRS) [27] . Functional outcome was evaluated using the mRS on day 90 after ICH onset. Favorable outcome was defined as mRS 0-3 and unfavorable outcome as mRS 4-6.
Imaging
As described previously [21] , we diagnosed ICH by CT (SOMATOM Volume Zoom or SOMATOM Definition AS+, Siemens Healthcare GmbH, Forchheim/Germany) or MRI (Siemens Magnetom Aera, 1.5T, Siemens Healthcare GmbH, Erlangen/ Germany). Two neuroradiologists (H.L. and P.H.) blinded to clinical data reviewed the scans independently and in cases of discrepancies made a second consensus analysis. We calculated ICH volume according to the ABC/2-formula and ABC/3-formula in irregularly shaped ICH [28, 29] . An increase in volume >33% upon follow-up was determined as hematoma enlargement [30] . Using the Graeb score summation, we scored the amount of intraventricular hematoma (IVH) [31] .
Statistical Analysis
We used the statistical software package SPSS 20.0 (IBM Analytics; www.spss etc.). The significance level was set at α = 0.05 twosided. We used the Kolmogorov-Smirnov test to determine the distribution of data. Data compared with normal distribution using the Student t test are presented as mean ± SD. Continuous variables without normal distribution were analyzed using the Mann-Whitney U test and obtained as median (50th) values and interquartile ranges (25th/75th). Categorical variables were presented as frequency and percentage. We used the Pearson chi square and the Fisher's exact tests to compare frequency distributions of categorized variables between patients with median split and 25th/75th-percentile NLROA. To identify parameters inde-
Results
NLR over Time -Prevalence, Related Factors, and Outcome
The median NLR of the entire cohort was 4.66 on admission; the nadir occurred at day 5 (NLR = 4.65; Fig. 1 Multivariable logistic regression models were performed to adjust for baseline confounders and to study possible independent effects of NLROA. NLROA was significantly associated with in-hospital mortality (NLROA: OR 0.967 [95% CI 0.939-0.997]; p = 0.029; online suppl. Table 1 ; for all online suppl. material, see www.karger. com/doi/10.1159/000468996) and showed a statistical trend on 3-month mortality (NLROA: OR 0.974 [95% CI 0.945-1.004]; p = 0.087; online suppl. Table 2 ). In contrast to published results [6] , we did not identify NLR as an independent variable for unfavorable functional outcome at 3 months (NLROA: OR 0.983 [95% CI 0.939-1.029]; p = 0.453; online suppl. Table 3 ). NLROA showed a statistical trend to be independently associated with development of a sepsis (NLROA: OR 1.028 [95% CI 0.998-1.059]; p < 0.071; online suppl. Table 4 ) and there were significant associations of NLROA and C-reactive protein (CRP) concentrations (mg/L) on admission ( p < 0.001, R 2 = 0.064; Fig. 3 ).
Clinical Significance of Increased and Decreased NLR
Given an average definition (NLR = 2.24) according to a nationally representative sample for healthy controls [26] , we compared patients with an NLR under the 25th-percentile (NLR <2.606) to those with an NLR ≥ 2.606, and patients with NLR above the 75th-percentile (NLR ≥ 8.508) to patients with NLR <8.508. Out of 855 patients, 214 had an NLR <2.606 ( Table 2 ) . These patients present- ( Table 3 ) .
Discussion
This study systematically investigated the natural course and clinical impact of NLR in a large cohort of ICH patients. As key findings, we observed increased baseline NLR levels compared to healthy individuals [26] . Further, an elevated NLR was linked to unfavorable baseline clinical and radiological parameters, increased infectious complications, as well as elevated c-reactive-protein levels on admission translating into worse clinical endpoints, notably an independent association of NLROA with inhospital mortality.
Our results are in line with previous data indicating that an elevated NLR is associated with early neurological deterioration [32] as well as increased short-term mortality rates [16] . Consistent with recent publications, in- Values are * n (%), ‡ median (interquartile range), or † mean ± SD. Bold values are significant, italic values show a statistical trend (i.e., p < 0.1). flammation was significantly associated with unfavorable outcome [16, 33, 34] ; however, we did not identify NLR as an independent predictor for outcome in ICH [6, 16] , which is in line with data from INTERACT2 [18, 35] . Regarding functional outcome and its possible relation to hematoma enlargement, Morotti et al. [19] -contrary to this study -found associations of higher neutrophil counts with reduced risk of hematoma expansion. The authors linked their finding to the hypothesis that the inflammatory response may exert beneficial aspects during the hyperacute phase such that activated neutrophils exhibit a procoagulant effect so that coagulation may be improved and therefore early hematoma expansion reduced [19] . However, there may also be an association of neutrophils, and NLR ratio respectively, with inflammatory complications [33, [36] [37] [38] . As demonstrated earlier, initial neutrophil infiltration contributes also to secondary brain injury [39] . The resulting expression of inflammatory markers, for example, interleukin-6 [12] and various pro-inflammatory cytokines [11, 12, 36, 38] may lead to further cellular DNA damage. Apoptosis and functional deactivation of peripheral lymphocytes [34, 40] reflect an important -though impaired -role in host defense. This can predispose to infectious complications later during hospital stay, as shown in our study. As NLR is known to be useful for the diagnosis of bacterial infections in patients with fever [41] , we showed significant associations of CRP concentrations and a trend to independent associations with sepsis.
Given the complex inflammatory process, there are various limitations of our study. This study lacks a prospective and multi-center design without specific blood sampling analyses. Regimens for diagnosis as well as treatment of infections have not been reported why the significance of reported associations may be weakened.
Although NLR did not significantly change among our ICH cohort during hospital stay, varying time points between stroke-onset, occurrence of infections and blood sampling may represent important potential confounders. However, excluding patients with elevated CRP levels on admission (>20 mg/L = twice the standard-level, and about 15% of our cohort) resulted in similar clinical endpoints (data not shown). Finally, we did not score for ICH etiologies, as there are probable associations between cerebral amyloid angiopathy and inflammation [42, 43] . Further, outcome analyses were based on selfreporting rather than on objectively blinded assessment. Although we accounted for statistical bias, findings of this study may still overestimate causal and clinical associations.
In conclusion, our data reveal increased baseline NLR levels in ICH, which is linked to unfavorable baseline parameters, increased infectious complications, and worse clinical endpoints. However, whether a close monitoring of specific subsets of ICH patients with increased NLR may result in beneficial outcome measures requires further investigations.
